Loading...
Thumbnail Image
Item

Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges

Howroyd, Fiona
MacDuff, Andrew
Gautam, Nandan
Pouchet, Brian
Tunnicliffe, Bill
Weblin, Jonathan
Gao-Smith, Fang
Ahmed, Zubair
Duggal, Niharika A
... show 1 more
Alternative
Abstract
Ventilator-associated pneumonia (VAP) affects up to 20% of critically ill patients and induces significant antibiotic prescription pressure, accounting for half of all antibiotic use in the ICU. VAP significantly increases hospital length of stay and healthcare costs yet is also associated with long-term morbidity and mortality. The diagnosis of VAP continues to present challenges and pitfalls for the currently available clinical, radiological and microbiological diagnostic armamentarium. Biomarkers and artificial intelligence offer an innovative potential direction for ongoing future research. In this Review, we summarise the pathobiological heterogeneity and diagnostic challenges associated with VAP.
Citation
Howroyd, F., Chacko, C., MacDuff, A. et al. Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges. Nat Commun 15, 6447 (2024). https://doi.org/10.1038/s41467-024-50805-z
Research Unit
PubMed ID
39085269 (pubmed)
PubMed Central ID
Embedded videos
Type
Journal article
Language
en
Description
© 2024 The Authors. Published by Nature Publishing Group. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1038/s41467-024-50805-z
Series/Report no.
ISSN
2041-1723
EISSN
2041-1723
ISBN
ISMN
Gov't Doc #
Sponsors
Rights
Licence for published version: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Research Projects
Organizational Units
Journal Issue
Embedded videos